What is KDL Pathology?
Headquartered in Plano, Texas, KDL Pathology operates as a comprehensive, full-service anatomic pathology laboratory. The firm maintains rigorous standards through its CAP Accreditation, positioning itself as a critical partner for clinicians and healthcare providers. By integrating state-of-the-art diagnostic technology with a team of highly specialized pathologists, the company delivers essential services ranging from dermatopathology to complex slide preparation. Its market position is defined by a focus on clinical accuracy and the optimization of patient outcomes through collaborative diagnostic workflows.
How much funding has KDL Pathology raised?
KDL Pathology has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in KDL Pathology
PPP
Public-Private Partnership
What's next for KDL Pathology?
The infusion of capital is expected to accelerate the company's strategic initiatives, particularly in the realm of technological integration and service expansion. As KDL Pathology navigates this late-stage growth phase, the focus will likely shift toward increasing laboratory throughput and deepening its integration with regional clinical networks. By leveraging this financing, the organization is well-positioned to enhance its diagnostic precision, thereby reinforcing its reputation as a reliable provider of high-acuity laboratory services in an increasingly data-driven medical environment.
See full KDL Pathology company page
